XML 57 R48.htm IDEA: XBRL DOCUMENT v3.23.3
Earnings Per Share - Summary (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Numerator:        
Net loss attributable to Surgery Partners, Inc. $ (4.9) $ (25.0) $ (10.9) $ (31.2)
Denominator:        
Weighted average shares outstanding- basic (shares) 125,747 88,907 125,559 88,604
Weighted average shares outstanding- diluted (shares) [1] 125,747 88,907 125,559 88,604
Loss per share:        
Basic (in USD per share) $ (0.04) $ (0.28) $ (0.09) $ (0.35)
Diluted (in USD per share) [1] $ (0.04) $ (0.28) $ (0.09) $ (0.35)
Stock options        
Loss per share:        
Dilutive securities outstanding not included in the computation of income (loss) per share as their effect is antidilutive (shares) 1,421 1,323 1,412 1,527
Restricted shares        
Loss per share:        
Dilutive securities outstanding not included in the computation of income (loss) per share as their effect is antidilutive (shares) 208 604 202 669
[1] The impact of potentially dilutive securities for all periods was not considered because the effect would be anti-dilutive.